<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="case-report" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Ophthalmol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Ophthalmology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Ophthalmol.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2674-0826</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fopht.2026.1736235</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>&#x201c;Preventing vision loss in pediatric otogenic thrombosis: a case report highlighting surgical interventions&#x201d;</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>AlMuhanna</surname><given-names>Fatimah A.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>*</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/3262560/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Hakami</surname><given-names>Wejdan S.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2187325/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
<contrib contrib-type="author">
<name><surname>AlHashem</surname><given-names>Abdullah M.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/3346685/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
<contrib contrib-type="author">
<name><surname>AlShahwan</surname><given-names>Eman</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
</contrib>
<contrib contrib-type="author">
<name><surname>AlHarbi</surname><given-names>Yazeed A.</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author">
<name><surname>AlShafi</surname><given-names>Shatha S.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>Division of Pediatric Neurology, Department of Pediatrics, Prince Sultan Military Medical City</institution>, <city>Riyadh</city>, <country country="sa">Saudi Arabia</country></aff>
<aff id="aff2"><label>2</label><institution>Division of Neuroradiology, Department of Radiology, Prince Sultan Military Medical City</institution>, <city>Riyadh</city>, <country country="sa">Saudi Arabia</country></aff>
<aff id="aff3"><label>3</label><institution>Division of Neuro-Ophthalmology, Department of Ophthalmology, Prince Sultan Military Medical City</institution>, <city>Riyadh</city>, <country country="sa">Saudi Arabia</country></aff>
<aff id="aff4"><label>4</label><institution>Department of Ophthalmology, Magrabi Health</institution>, <city>Riyadh</city>, <country country="sa">Saudi Arabia</country></aff>
<author-notes>
<corresp id="c001"><label>*</label>Correspondence: Fatimah A. AlMuhanna, <email xlink:href="mailto:Fatimah.abd.Muh@gmail.com">Fatimah.abd.Muh@gmail.com</email></corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-02-25">
<day>25</day>
<month>02</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>6</volume>
<elocation-id>1736235</elocation-id>
<history>
<date date-type="received">
<day>30</day>
<month>10</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>01</month>
<year>2026</year>
</date>
<date date-type="rev-recd">
<day>21</day>
<month>01</month>
<year>2026</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2026 AlMuhanna, Hakami, AlHashem, AlShahwan, AlHarbi and AlShafi.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>AlMuhanna, Hakami, AlHashem, AlShahwan, AlHarbi and AlShafi</copyright-holder>
<license>
<ali:license_ref start_date="2026-02-25">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Otogenic cerebral venous sinus thrombosis (CVST) is a rare complication of acute otitis media in children and may lead to severe intracranial hypertension with vision-threatening papilledema. We report the case of a 4-year-old girl with otogenic CVST involving the left transverse and sigmoid sinuses, complicated by marked intracranial hypertension and bilateral Fris&#xe9;n grade 4 papilledema. Serial ophthalmologic assessments and neuroimaging were performed to evaluate the response to sequential therapeutic interventions. Despite treatment with intravenous antibiotics, anticoagulation, and medical intracranial pressure&#x2013;lowering therapy, papilledema and symptoms persisted. Optic nerve sheath fenestration (ONSF) resulted in partial improvement; however, subsequent temporary external lumbar drainage led to rapid and sustained resolution of papilledema, headache, and left abducens nerve palsy, with preservation of visual function. This case underscores the importance of a structured, stepwise escalation strategy incorporating both vision-directed and global intracranial pressure&#x2013;lowering interventions when medical therapy alone is insufficient.</p>
</abstract>
<kwd-group>
<kwd>intracranial hypertension</kwd>
<kwd>lumbar drainage</kwd>
<kwd>optic nerve sheath fenestration</kwd>
<kwd>otogenic CVST</kwd>
<kwd>pediatric papilledema</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declared that financial support was not received for this work and/or its publication.</funding-statement>
</funding-group>
<counts>
<fig-count count="4"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="16"/>
<page-count count="7"/>
<word-count count="2017"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Neuro-Ophthalmology Disorders</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Acute otitis media is among the most common infectious conditions in childhood, with approximately 60% of children experiencing at least one episode by age three (<xref ref-type="bibr" rid="B1">1</xref>). Although uncommon, it may progress to otogenic cerebral venous sinus thrombosis (CVST), a serious intracranial complication with a reported prevalence between 0.2% and 2.7% (<xref ref-type="bibr" rid="B2">2</xref>). Thrombosis of the transverse or sigmoid sinus impairs venous outflow and cerebrospinal fluid (CSF) absorption, leading to elevated intracranial pressure (ICP), papilledema, and risk of permanent visual loss (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>).</p>
<p>While medical therapy with antibiotics, anticoagulation, and ICP-lowering agents remains first-line treatment, guidance regarding surgical escalation for vision preservation is limited (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>).Optic nerve sheath fenestration (ONSF) and CSF diversion procedures have been reported individually (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>), but their sequential use in pediatric otogenic CVST is not well defined (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>).</p>
<p>We report a pediatric case of otogenic cerebral venous sinus thrombosis with severe intracranial hypertension and vision-threatening papilledema, illustrating a stepwise neuro-ophthalmic management approach using optic nerve sheath fenestration followed by temporary lumbar drainage. This case emphasizes the role of timely, multidisciplinary intervention in preserving visual function when medical therapy alone is inadequate.</p>
</sec>
<sec id="s2">
<title>Case description</title>
<sec id="s2_1">
<title>Clinical presentation</title>
<p>A previously healthy 4-year-old girl presented with a 3-day history of fever and left otalgia, followed by progressive headache, vomiting, photophobia, diplopia, and neck discomfort.</p>
</sec>
<sec id="s2_2">
<title>Clinical findings</title>
<p>Neuro-ophthalmologic examination demonstrated severe bilateral papilledema (Fris&#xe9;n grade 4 OU) accompanied by a left abducens nerve palsy. Assessment of visual acuity was limited by patient discomfort and was confined to qualitative measures, revealing finger counting at close distance in the right eye and hand-motion perception in the left eye; reliable quantitative acuity testing was not feasible. Fixation and tracking were preserved, and pupillary responses were symmetric without a relative afferent pupillary defect. Formal visual field testing was not performed due to the patient&#x2019;s age and discomfort, while optical coherence tomography could not be obtained at presentation because of limited patient cooperation.</p>
</sec>
</sec>
<sec id="s3">
<title>Diagnostic assessment</title>
<p>Lumbar puncture demonstrated an opening pressure of 42 cm H<sub>2</sub>O with normal CSF cell counts and sterile cultures. Contrast-enhanced CT venography and MR venography confirmed complete thrombosis of the left transverse and sigmoid sinuses extending into the jugular bulb. MRI showed optic nerve sheath distension and posterior scleral flattening, consistent with elevated ICP (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1</bold></xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Baseline neuroimaging prior to treatment. <bold>(A)</bold> 2 Axial and one coronal T2-weighted MRI of the brain and orbits at the level of optic nerve heads, demonstrate dilatation of the optic nerve sheath complexes with tenting of the optic nerve heads and flattening of the posterior globes, consistent with elevated intracranial pressure. <bold>(B)</bold> MR venography demonstrates thrombosis of the left transverse sinus, sigmoid sinus, and jugular bulb, with non-enhancing filling defects.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fopht-06-1736235-g001.tif">
<alt-text content-type="machine-generated">Panel A displays three brain MRI scans, with two axial views and one coronal view highlighting cerebral structures and fluids. Panel B shows a coronal MRI of cerebral vasculature, depicting blood vessels.</alt-text>
</graphic></fig>
</sec>
<sec id="s4">
<title>Therapeutic interventions</title>
<sec id="s4_1">
<title>Medical management</title>
<p>The patient was managed with intravenous ceftriaxone and vancomycin, subcutaneous low-molecular-weight heparin (20 mg twice daily; anti-Xa target 0.75&#x2013;1.0), and acetazolamide, titrated to a maximum dose of 25 mg/kg/day. Furosemide (1 mg/kg/day) was subsequently added. Although the left abducens nerve palsy improved, headache persisted, and papilledema remained severe on follow-up examination (Fris&#xe9;n grade 3 in the right eye and grade 4 in the left eye).</p>
</sec>
<sec id="s4_2">
<title>Optic nerve sheath fenestration</title>
<p>Optic nerve sheath fenestration was performed on hospital day 21 due to persistent, vision-threatening papilledema refractory to maximal medical therapy. On preoperative examination (day 20), papilledema was graded as grade 3 in the right eye and grade 4 in the left eye. By postoperative day 2 (day 23), papilledema in the left eye had improved to grade 3.</p>
</sec>
<sec id="s4_3">
<title>Lumbar drain placement</title>
<p>Given the lack of adequate clinical and ophthalmic improvement in papilledema, headache, and left sixth cranial nerve palsy despite maximal medical therapy and prior optic nerve sheath fenestration consistent with persistent intracranial hypertension, a temporary lumbar drain was placed for a total duration of six days. The opening cerebrospinal fluid (CSF) pressure was elevated at 38 cm H<sub>2</sub>O. Continuous CSF drainage was performed at a rate of 5&#x2013;10 mL/hour under strict aseptic conditions. No procedure-related complications were encountered.</p>
<p>Following CSF diversion, there was a marked clinical and ophthalmic response. Papilledema improved to Fris&#xe9;n grade 1 bilaterally, with complete resolution of headache and left sixth cranial nerve palsy.</p>
</sec>
<sec id="s4_4">
<title>Follow-up and outcomes</title>
<p>At discharge (week 6), the patient was clinically stable and discharged on ongoing anticoagulation therapy, with acetazolamide and furosemide gradually tapered. Ophthalmologic examination at that time demonstrated residual mild papilledema (Fris&#xe9;n grade 1 OU), with complete resolution of headache and left abducens nerve palsy.</p>
<p>At the two-month follow-up, the patient showed complete clinical and ophthalmologic recovery. Fundoscopic examination confirmed full resolution of papilledema. Optical coherence tomography (OCT) demonstrated normalization of retinal nerve fiber layer (RNFL) thickness bilaterally (OD: 127 &#xb5;m; OS: 122 &#xb5;m; <xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2</bold></xref>). Brain magnetic resonance imaging (MRI) revealed restoration of posterior globe concavity with reduction in optic nerve sheath diameter (<xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3</bold></xref>), while magnetic resonance venography (MRV) showed partial recanalization of the left transverse and sigmoid sinuses. Clinically, the patient reported complete resolution of headache, and neurological examination confirmed full recovery of the left abducens nerve palsy.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Ophthalmologic findings at two-month follow-up. Fundoscopic examination demonstrates complete resolution of optic disc edema in both eyes following left optic nerve sheath fenestration and temporary lumbar drainage. Optical coherence tomography shows near-normalization of retinal nerve fiber layer thickness, consistent with resolving papilledema.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fopht-06-1736235-g002.tif">
<alt-text content-type="machine-generated">Two ophthalmic diagnostic images show retinal scans. The top image represents the right eye (OD) with detailed retinal thickness and surface maps, color-coded charts, and a circular thickness graph. The bottom image represents the left eye (OS) with similar diagnostic details and imaging. Both images include cross-sectional views of the retina, visual field representations, and quality metrics.</alt-text>
</graphic></fig>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Follow-up neuroimaging after treatment. <bold>(A, B)</bold> Axial and coronal T2-weighted MRI of the brain and orbits at the level of optic nerve heads obtained after optic nerve sheath fenestration and lumbar puncture demonstrate a marked reduction in optic nerve sheath dilatation, with improvement in posterior scleral flattening, consistent with resolution of elevated intracranial pressure. Interval improvement is evident on the most recent imaging <bold>(B)</bold> compared with earlier post-treatment imaging <bold>(A, C)</bold> MR venography demonstrates partial recanalization of the left transverse sinus with improved opacification of the left sigmoid sinus and jugular bulb.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fopht-06-1736235-g003.tif">
<alt-text content-type="machine-generated">Three-panel image of brain scans labeled A, B, and C. Panel A shows an axial MRI scan highlighting the eyes and brain structure. Panel B presents a coronal view of the brain with visible cerebral features. Panel C displays an angiogram revealing blood vessels in the brain.</alt-text>
</graphic></fig>
<p>Low-molecular-weight heparin was continued for a total duration of approximately three months, given the provoked nature of the cerebral venous sinus thrombosis and the absence of clinical or radiological progression. A consolidated overview of the clinical course, therapeutic interventions, and ophthalmologic outcomes is presented in the timeline (<xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4</bold></xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Ophthalmologic course and stepwise therapeutic escalation. <bold>(A)</bold> Serial ophthalmologic examinations and interventions from presentation through two-month follow-up. <bold>(B)</bold> Schematic timeline illustrating stepwise escalation from medical therapy to optic nerve sheath fenestration and subsequent temporary lumbar drainage, resulting in complete resolution of papilledema with full recovery of visual function and headache. CF, counting fingers; HM, hand motion; RAPD, relative afferent pupillary defect; ONSF, optic nerve sheath fenestration; LD, lumbar drainage; LMWH, low-molecular-weight heparin. IV, intravenous; CN VI, sixth cranial nerve; OCT, optical coherence tomography; RNFL, of retinal nerve fiber layer thickness; LP, lumbar puncture.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fopht-06-1736235-g004.tif">
<alt-text content-type="machine-generated">Table A shows a clinical timeline with time points including presentation, Day 5, Day 12, Day 20, Day 23, Day 30, Day 32, discharge, and 2-month follow-up. It tracks papilledema, visual assessment, neurologic findings, and interventions with noted improvements and treatments like antibiotics and lumbar drainage.   Diagram B is a timeline visual of the treatment process, marking key points: presentation, pre-ONSF Day 20, post-ONSF Day 23, post-lumbar drain Day 32, and a 2-month follow-up. It summarizes medical therapy and outcomes for papilledema and headaches. Abbreviations are provided at the bottom.</alt-text>
</graphic></fig>
</sec>
</sec>
<sec id="s5" sec-type="discussion">
<title>Discussion</title>
<p>Otogenic cerebral venous sinus thrombosis (CVST) is an uncommon but potentially life-threatening complication of acute otitis media in children, with reported mortality reaching 5&#x2013;10% and significant risk for neurological and visual morbidity when diagnosis or treatment is delayed (<xref ref-type="bibr" rid="B4">4</xref>). Thrombosis most often involves the transverse and sigmoid sinuses due to their proximity to the mastoid air cells, where local inflammation can promote endothelial injury, platelet activation, and fibrin deposition, resulting in mural thrombus formation and possible propagation into the jugular bulb and petrosal sinuses (<xref ref-type="bibr" rid="B5">5</xref>). Impaired venous outflow disrupts cerebrospinal fluid (CSF) absorption, leading to otitic intracranial hypertension characterized by elevated intracranial pressure (ICP) and papilledema.</p>
<p>Clinical symptoms frequently begin with otologic features such as fever, otalgia, and otorrhea, followed by neurological or ophthalmic manifestations related to raised ICP. In pediatric cohorts, papilledema, abducens nerve palsy, diplopia, facial nerve palsy, headache, nausea, lethargy, and seizures are among the most commonly reported findings (<xref ref-type="bibr" rid="B11">11</xref>). These features were evident in our patient, whose bilateral severe papilledema and cranial nerve VI palsy reflected substantial intracranial hypertension.</p>
<p>Initial management universally includes broad-spectrum intravenous antibiotics and anticoagulation to prevent thrombus propagation and support restoration of venous drainage (<xref ref-type="bibr" rid="B6">6</xref>). Surgical interventions such as mastoidectomy or abscess drainage are generally reserved for cases with persistent infection or progressive intracranial complications despite adequate medical therapy (<xref ref-type="bibr" rid="B9">9</xref>). However, management becomes more challenging when visual function is threatened by refractory intracranial hypertension, and consensus regarding the optimal escalation strategy remains limited (<xref ref-type="bibr" rid="B12">12</xref>).</p>
<p>In this patient, papilledema persisted at Fris&#xe9;n grade 3&#x2013;4 despite maximal medical therapy, placing the optic nerves at imminent risk of irreversible injury. Management was therefore guided by previously reported strategies for vision-threatening papilledema in cerebral venous sinus thrombosis (CVST). Optic nerve sheath fenestration (ONSF) was selected as the initial surgical intervention because progressive papilledema and visual risk were the dominant clinical concerns, consistent with published evidence demonstrating that ONSF can stabilize or improve visual outcomes in CVST when medical therapy alone is insufficient (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B14">14</xref>).</p>
<p>Although ONSF resulted in improvement of papilledema in the operated eye, persistent edema in the contralateral eye indicated ongoing global intracranial pressure (ICP) elevation, a limitation that has been well described in prior studies (<xref ref-type="bibr" rid="B13">13</xref>). This incomplete bilateral response was further supported by neuroimaging findings, including optic nerve sheath distension and posterior globe flattening, which are recognized radiologic markers of sustained intracranial hypertension. These findings suggested that, while ONSF effectively protected the optic nerve locally, it did not adequately address the underlying global ICP burden related to persistent venous outflow obstruction.</p>
<p>Consequently, escalation to temporary lumbar drainage was undertaken to achieve systemic CSF diversion, an approach supported in refractory intracranial hypertension as a temporizing measure when permanent CSF diversion is undesirable, particularly in the setting of recent infection (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>). In our patient, lumbar drainage resulted in rapid bilateral improvement in papilledema, preventing the need for permanent CSF shunting. This clinical course supports a complementary, stepwise management strategy, in which ONSF serves to protect optic nerve function while lumbar drainage addresses global ICP elevation, in alignment with previously published experience.</p>
<p>This case contributes to the limited pediatric literature by providing detailed sequential ophthalmologic and radiologic documentation, illustrating how targeted interventions can preserve visual function in otogenic CVST with severe ICP elevation. Strengths of the report include high-quality imaging correlation and detailed examination timelines, while limitations include the inability to obtain pre-treatment OCT or formal visual acuity due to young age and symptom severity.</p>
</sec>
<sec id="s6">
<title>Patient perspective</title>
<p>The patient&#x2019;s family expressed concern about potential permanent vision loss but reported feeling reassured by frequent updates and clear explanations of the treatment plan. They noted significant rapid improvement after lumbar drainage and expressed satisfaction with the final visual outcome.</p>
</sec>
</body>
<back>
<sec id="s7" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/supplementary material. Further inquiries can be directed to the corresponding author.</p></sec>
<sec id="s8" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>Written informed consent was obtained from the individual(s), and minor(s)&#x2019; legal guardian/next of kin, for the publication of any potentially identifiable images or data included in this article. Written informed consent was obtained from the participant/patient(s) for the publication of this case report.</p></sec>
<sec id="s9" sec-type="author-contributions">
<title>Author contributions</title>
<p>FA: Writing &#x2013; review &amp; editing, Writing &#x2013; original draft, Data curation, Conceptualization.  WH: Writing &#x2013; review &amp; editing, Conceptualization, Supervision, Writing &#x2013; original draft. AA: Visualization, Writing &#x2013; review &amp; editing, Writing &#x2013; original draft, Formal analysis. EA: Visualization, Writing &#x2013; review &amp; editing. YA: Writing &#x2013; original draft, Visualization, Writing &#x2013; review &amp; editing. SSA: Data curation, Writing &#x2013; review &amp; editing, Writing &#x2013; original draft.</p></sec>
<sec id="s11" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec>
<sec id="s12" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declared that generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If&#xa0;you identify any issues, please contact us.</p></sec>
<sec id="s13" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chiappini</surname> <given-names>E</given-names></name>
<name><surname>Marchisio</surname> <given-names>P</given-names></name>
</person-group>. 
<article-title>Updated guidelines for the management of acute otitis media in children</article-title>. <source>Pediatr Infect Dis J</source>. (<year>2019</year>) <volume>38</volume>:<page-range>e317&#x2013;30</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/INF.0000000000002452</pub-id>, PMID: <pub-id pub-id-type="pmid">31876601</pub-id>
</mixed-citation>
</ref>
<ref id="B2">
<label>2</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wong</surname> <given-names>BY</given-names></name>
<name><surname>Hickman</surname> <given-names>S</given-names></name>
<name><surname>Richards</surname> <given-names>M</given-names></name>
<name><surname>Jassar</surname> <given-names>P</given-names></name>
<name><surname>Wilson</surname> <given-names>T.</given-names></name>
</person-group> 
<article-title>Management of paediatric otogenic cerebral venous sinus thrombosis</article-title>. <source>Clin Otolaryngol</source>. (<year>2015</year>) <volume>40</volume>:<page-range>563&#x2013;70</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/coa.12504</pub-id>, PMID: <pub-id pub-id-type="pmid">26769686</pub-id>
</mixed-citation>
</ref>
<ref id="B3">
<label>3</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Coutinho</surname> <given-names>G</given-names></name>
<name><surname>J&#xfa;lio</surname> <given-names>S</given-names></name>
<name><surname>Matos</surname> <given-names>R</given-names></name>
<name><surname>Santos</surname> <given-names>M</given-names></name>
<name><surname>Spratley</surname> <given-names>J</given-names></name>
</person-group>. 
<article-title>Otogenic cerebral venous thrombosis in children</article-title>. <source>Int J Pediatr Otorhinolaryngol</source>. (<year>2018</year>) <volume>108</volume>:<page-range>84&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ijporl.2018.07.050</pub-id>, PMID: <pub-id pub-id-type="pmid">30173980</pub-id>
</mixed-citation>
</ref>
<ref id="B4">
<label>4</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Smith</surname> <given-names>JA</given-names></name>
<name><surname>Danner</surname> <given-names>CJ</given-names></name>
</person-group>. 
<article-title>Complications of chronic otitis media and cholesteatoma</article-title>. <source>Otolaryngol Clin North Am</source>. (<year>2006</year>) <volume>39</volume>:<page-range>1237&#x2013;55</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.otc.2006.09.001</pub-id>, PMID: <pub-id pub-id-type="pmid">17097444</pub-id>
</mixed-citation>
</ref>
<ref id="B5">
<label>5</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ghosh</surname> <given-names>PS</given-names></name>
<name><surname>Ghosh</surname> <given-names>D</given-names></name>
<name><surname>Goldfarb</surname> <given-names>J</given-names></name>
<name><surname>Sabella</surname> <given-names>C</given-names></name>
</person-group>. 
<article-title>Lateral sinus thrombosis associated with mastoiditis and otitis media in children</article-title>. <source>J Child Neurol</source>. (<year>2011</year>) <volume>26</volume>:<page-range>1000&#x2013;4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/0883073811401745</pub-id>, PMID: <pub-id pub-id-type="pmid">21540368</pub-id>
</mixed-citation>
</ref>
<ref id="B6">
<label>6</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Au</surname> <given-names>JK</given-names></name>
<name><surname>Adam</surname> <given-names>SI</given-names></name>
<name><surname>Michaelides</surname> <given-names>EM</given-names></name>
</person-group>. 
<article-title>Contemporary management of pediatric lateral sinus thrombosis</article-title>. <source>Am J Otolaryngol</source>. (<year>2013</year>) <volume>34</volume>:<page-range>145&#x2013;50</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.amjoto.2012.09.011</pub-id>, PMID: <pub-id pub-id-type="pmid">23177380</pub-id>
</mixed-citation>
</ref>
<ref id="B7">
<label>7</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bevan</surname> <given-names>R</given-names></name>
<name><surname>Patel</surname> <given-names>C</given-names></name>
<name><surname>Bhatti</surname> <given-names>I</given-names></name>
<name><surname>Te</surname> <given-names>Water NJ</given-names></name>
<name><surname>Gibbon</surname> <given-names>F</given-names></name>
<name><surname>Leach</surname> <given-names>P</given-names></name>
<etal/>
</person-group>. 
<article-title>Surgical management of raised intracranial pressure secondary to otogenic infection</article-title>. <source>Childs Nerv Syst</source>. (<year>2020</year>) <volume>36</volume>:<page-range>1495&#x2013;502</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00381-019-04353-3</pub-id>, PMID: <pub-id pub-id-type="pmid">31444559</pub-id>
</mixed-citation>
</ref>
<ref id="B8">
<label>8</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Sitton</surname> <given-names>MS</given-names></name>
<name><surname>Chun</surname> <given-names>R</given-names></name>
</person-group>. 
<article-title>Pediatric otogenic lateral sinus thrombosis: role of anticoagulation and surgery</article-title>. <source>Int J Pediatr Otorhinolaryngol</source>. (<year>2012</year>) <volume>76</volume>:<page-range>428&#x2013;32</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ijporl.2011.12.025</pub-id>, PMID: <pub-id pub-id-type="pmid">22277267</pub-id>
</mixed-citation>
</ref>
<ref id="B9">
<label>9</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bradley</surname> <given-names>DT</given-names></name>
<name><surname>Hashisaki</surname> <given-names>GT</given-names></name>
<name><surname>Mason</surname> <given-names>JC</given-names></name>
</person-group>. 
<article-title>Otogenic sigmoid sinus thrombosis: what is the role of anticoagulation</article-title>? <source>Laryngoscope.</source> (<year>2002</year>) <volume>112</volume>:<page-range>1726&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/00005537-200210000-00003</pub-id>, PMID: <pub-id pub-id-type="pmid">12368604</pub-id>
</mixed-citation>
</ref>
<ref id="B10">
<label>10</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Scorpecci</surname> <given-names>A</given-names></name>
<name><surname>Massoud</surname> <given-names>M</given-names></name>
<name><surname>Giannantonio</surname> <given-names>S</given-names></name>
<name><surname>Zangari</surname> <given-names>P</given-names></name>
<name><surname>Lucidi</surname> <given-names>D</given-names></name>
<name><surname>Martines</surname> <given-names>F</given-names></name>
<etal/>
</person-group>. 
<article-title>Otogenic lateral sinus thrombosis in children</article-title>. <source>Eur Arch Otorhinolaryngol</source>. (<year>2018</year>) <volume>275</volume>:<page-range>1971&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00405-018-5033-1</pub-id>, PMID: <pub-id pub-id-type="pmid">29948264</pub-id>
</mixed-citation>
</ref>
<ref id="B11">
<label>11</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lu</surname> <given-names>VM</given-names></name>
<name><surname>Abou-Al-Shaar</surname> <given-names>H</given-names></name>
<name><surname>Rangwala</surname> <given-names>SD</given-names></name>
<etal/>
</person-group>. 
<article-title>Neurosurgical outcomes of pediatric cerebral venous sinus thrombosis after mastoiditis</article-title>. <source>J Neurosurg Pediatr</source>. (<year>2023</year>) <volume>31</volume>:<page-range>410&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3171/2023.2.PEDS2319</pub-id>, PMID: <pub-id pub-id-type="pmid">37060317</pub-id>
</mixed-citation>
</ref>
<ref id="B12">
<label>12</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Dotan</surname> <given-names>G</given-names></name>
<name><surname>Cohen</surname> <given-names>NH</given-names></name>
<name><surname>Qureshi</surname> <given-names>HM</given-names></name>
<etal/>
</person-group>. 
<article-title>External lumbar drainage in pediatric intracranial hypertension</article-title>. <source>J Neurosurg Pediatr</source>. (<year>2021</year>) <volume>28</volume>:<page-range>553&#x2013;60</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3171/2021.2.PEDS2143</pub-id>, PMID: <pub-id pub-id-type="pmid">34271543</pub-id>
</mixed-citation>
</ref>
<ref id="B13">
<label>13</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Li</surname> <given-names>Z</given-names></name>
<name><surname>Cheng</surname> <given-names>L</given-names></name>
<name><surname>Xu</surname> <given-names>Y</given-names></name>
<name><surname>Sun</surname> <given-names>Q</given-names></name>
<name><surname>Zhang</surname> <given-names>J</given-names></name>
<name><surname>Bai</surname> <given-names>L</given-names></name>
<etal/>
</person-group>. 
<article-title>Optic nerve sheath fenestration for progressive visual loss in cerebral venous sinus thrombosis: a long-term retrospective observational study</article-title>. <source>Neurol Ther</source>. (<year>2023</year>) <volume>12</volume>:<page-range>441&#x2013;57</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s40120-022-00434-9</pub-id>, PMID: <pub-id pub-id-type="pmid">36609961</pub-id>
</mixed-citation>
</ref>
<ref id="B14">
<label>14</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Elnahry</surname> <given-names>AG</given-names></name>
<name><surname>Talbet</surname> <given-names>JH</given-names></name>
<name><surname>El Mahgoub</surname> <given-names>IR</given-names></name>
<name><surname>Elnahry</surname> <given-names>GA</given-names></name>
</person-group>. 
<article-title>Optic nerve sheath fenestration for papilledema due to cerebral venous sinus thrombosis associated with antiphospholipid syndrome: a case report</article-title>. <source>Am J Case Rep</source>. (<year>2021</year>) <volume>22</volume>:<fpage>e930497</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.12659/AJCR.930497</pub-id>, PMID: <pub-id pub-id-type="pmid">34029308</pub-id>
</mixed-citation>
</ref>
<ref id="B15">
<label>15</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Saposnik</surname> <given-names>G</given-names></name>
<name><surname>Bushnell</surname> <given-names>C</given-names></name>
<name><surname>Coutinho</surname> <given-names>JM</given-names></name>
<name><surname>Field</surname> <given-names>TS</given-names></name>
<name><surname>Furie</surname> <given-names>KL</given-names></name>
<name><surname>Galadanci</surname> <given-names>N</given-names></name>
<etal/>
</person-group>. 
<article-title>Diagnosis and management of cerebral venous thrombosis: a scientific statement from the American Heart Association</article-title>. <source>Stroke.</source> (<year>2024</year>) <volume>55</volume>:<page-range>e77&#x2013;90</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/STR.0000000000000456</pub-id>, PMID: <pub-id pub-id-type="pmid">38284265</pub-id>
</mixed-citation>
</ref>
<ref id="B16">
<label>16</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Sefick</surname> <given-names>SL</given-names></name>
<name><surname>Rizk</surname> <given-names>EB</given-names></name>
<name><surname>Even</surname> <given-names>KM</given-names></name>
</person-group>. 
<article-title>Management of pediatric nontraumatic intracranial hypertension with a lumbar drain: illustrative cases</article-title>. <source>J Neurosurg Case Lessons</source>. (<year>2025</year>) <volume>10</volume>:<elocation-id>CASE25209</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3171/CASE25209</pub-id>, PMID: <pub-id pub-id-type="pmid">41343782</pub-id>
</mixed-citation>
</ref>
</ref-list>
<fn-group>
<fn id="n1" fn-type="custom" custom-type="edited-by">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1765424">Sachin Kedar</ext-link>, Emory University, United States</p></fn>
<fn id="n2" fn-type="custom" custom-type="reviewed-by">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1353127">Bart Chwalisz</ext-link>, Massachusetts General Hospital and Harvard Medical School, United States</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3323729">Taiga Inooka</ext-link>, Kamiya Ganka, Japan</p></fn>
</fn-group>
</back>
</article>